Publication | Closed Access
Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin
144
Citations
15
References
2008
Year
Intravesical BC-819 causes tumor ablation following intravesical administration at doses that were well tolerated. It is worthy of continued clinical investigation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1